Medical - Healthcare Information Services
Compare Stocks
4 / 10Stock Comparison
TBRG vs TDOC vs AMWL vs HIMS
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Information Services
Medical - Healthcare Information Services
Medical - Equipment & Services
TBRG vs TDOC vs AMWL vs HIMS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Healthcare Information Services | Medical - Healthcare Information Services | Medical - Healthcare Information Services | Medical - Equipment & Services |
| Market Cap | $387M | $1.26B | $129M | $6.63B |
| Revenue (TTM) | $347M | $2.51B | $182M | $2.35B |
| Net Income (TTM) | $4M | $-171M | $-88M | $128M |
| Gross Margin | 53.0% | 65.6% | 38.7% | 69.7% |
| Operating Margin | 6.0% | -7.6% | -50.6% | 4.6% |
| Forward P/E | 10.1x | — | — | 51.5x |
| Total Debt | $167M | $1.04B | $5M | $1.12B |
| Cash & Equiv. | $25M | $781M | $182M | $229M |
TBRG vs TDOC vs AMWL vs HIMS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 20 | May 26 | Return |
|---|---|---|---|
| TruBridge, Inc. (TBRG) | 100 | 93.4 | -6.6% |
| Teladoc Health, Inc. (TDOC) | 100 | 3.2 | -96.8% |
| American Well Corpo… (AMWL) | 100 | 1.3 | -98.7% |
| Hims & Hers Health,… (HIMS) | 100 | 218.4 | +118.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TBRG vs TDOC vs AMWL vs HIMS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TBRG is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- Dividend streak 0 yrs, beta 0.94
- Rev growth 1.2%, EPS growth 121.0%, 3Y rev CAGR 2.0%
- Lower P/E (10.1x vs 51.5x)
- Beta 0.94 vs HIMS's 2.40, lower leverage
TDOC lags the leaders in this set but could rank higher in a more targeted comparison.
AMWL is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 1.47, Low D/E 1.8%, current ratio 3.37x
- Beta 1.47, current ratio 3.37x
- +14.3% vs HIMS's -51.0%
HIMS carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 161.9% 10Y total return vs TBRG's -36.0%
- 59.0% revenue growth vs AMWL's -2.0%
- 5.5% margin vs AMWL's -48.2%
- 6.0% ROA vs AMWL's -25.1%, ROIC 10.7% vs -95.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 59.0% revenue growth vs AMWL's -2.0% | |
| Value | Lower P/E (10.1x vs 51.5x) | |
| Quality / Margins | 5.5% margin vs AMWL's -48.2% | |
| Stability / Safety | Beta 0.94 vs HIMS's 2.40, lower leverage | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +14.3% vs HIMS's -51.0% | |
| Efficiency (ROA) | 6.0% ROA vs AMWL's -25.1%, ROIC 10.7% vs -95.1% |
TBRG vs TDOC vs AMWL vs HIMS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
TBRG vs TDOC vs AMWL vs HIMS — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HIMS leads in 2 of 6 categories
TDOC leads 1 • TBRG leads 1 • AMWL leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HIMS leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
TDOC is the larger business by revenue, generating $2.5B annually — 13.8x AMWL's $182M. HIMS is the more profitable business, keeping 5.5% of every revenue dollar as net income compared to AMWL's -48.2%. On growth, HIMS holds the edge at +28.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $347M | $2.5B | $182M | $2.3B |
| EBITDAEarnings before interest/tax | $47M | $42M | -$59M | $164M |
| Net IncomeAfter-tax profit | $4M | -$171M | -$88M | $128M |
| Free Cash FlowCash after capex | $32M | $251M | -$42M | $73M |
| Gross MarginGross profit ÷ Revenue | +53.0% | +65.6% | +38.7% | +69.7% |
| Operating MarginEBIT ÷ Revenue | +6.0% | -7.6% | -50.6% | +4.6% |
| Net MarginNet income ÷ Revenue | +1.3% | -6.8% | -48.2% | +5.5% |
| FCF MarginFCF ÷ Revenue | +9.1% | +10.0% | -22.9% | +3.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.4% | -2.5% | -100.0% | +28.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +28.2% | +32.1% | +44.5% | -27.3% |
Valuation Metrics
TDOC leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 50.3x trailing earnings, HIMS trades at a 43% valuation discount to TBRG's 88.9x P/E. On an enterprise value basis, TBRG's 8.8x EV/EBITDA is more attractive than HIMS's 42.7x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $387M | $1.3B | $129M | $6.6B |
| Enterprise ValueMkt cap + debt − cash | $529M | $1.5B | -$48M | $7.5B |
| Trailing P/EPrice ÷ TTM EPS | 88.90x | -6.11x | -1.30x | 50.32x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.14x | — | — | 51.51x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 8.81x | 15.13x | — | 42.68x |
| Price / SalesMarket cap ÷ Revenue | 1.11x | 0.50x | 0.52x | 2.82x |
| Price / BookPrice ÷ Book value/share | 2.10x | 0.89x | 0.50x | 12.25x |
| Price / FCFMarket cap ÷ FCF | 10.85x | 4.40x | — | 89.61x |
Profitability & Efficiency
Evenly matched — AMWL and HIMS each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
HIMS delivers a 23.7% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $-33 for AMWL. AMWL carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to HIMS's 2.07x. On the Piotroski fundamental quality scale (0–9), TBRG scores 6/9 vs HIMS's 4/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +2.5% | -12.4% | -33.5% | +23.7% |
| ROA (TTM)Return on assets | +1.1% | -5.9% | -25.1% | +6.0% |
| ROICReturn on invested capital | +7.8% | -11.5% | -95.1% | +10.7% |
| ROCEReturn on capital employed | +9.8% | -10.0% | -36.6% | +10.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.94x | 0.75x | 0.02x | 2.07x |
| Net DebtTotal debt minus cash | $142M | $259M | -$178M | $892M |
| Cash & Equiv.Liquid assets | $25M | $781M | $182M | $229M |
| Total DebtShort + long-term debt | $167M | $1.0B | $5M | $1.1B |
| Interest CoverageEBIT ÷ Interest expense | 1.31x | -8.76x | -239.18x | — |
Total Returns (Dividends Reinvested)
HIMS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HIMS five years ago would be worth $23,764 today (with dividends reinvested), compared to $278 for AMWL. Over the past 12 months, AMWL leads with a +14.3% total return vs HIMS's -51.0%. The 3-year compound annual growth rate (CAGR) favors HIMS at 29.4% vs AMWL's -42.2% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +23.3% | -1.3% | +59.8% | -23.2% |
| 1-Year ReturnPast 12 months | +1.1% | +1.5% | +14.3% | -51.0% |
| 3-Year ReturnCumulative with dividends | -0.5% | -73.3% | -80.7% | +116.6% |
| 5-Year ReturnCumulative with dividends | -17.4% | -95.4% | -97.2% | +137.6% |
| 10-Year ReturnCumulative with dividends | -36.0% | -41.1% | -98.3% | +161.9% |
| CAGR (3Y)Annualised 3-year return | -0.2% | -35.6% | -42.2% | +29.4% |
Risk & Volatility
TBRG leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
TBRG is the less volatile stock with a 0.94 beta — it tends to amplify market swings less than HIMS's 2.40 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TBRG currently trades 96.6% from its 52-week high vs HIMS's 36.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.94x | 1.91x | 1.47x | 2.40x |
| 52-Week HighHighest price in past year | $26.68 | $9.77 | $9.15 | $70.43 |
| 52-Week LowLowest price in past year | $13.88 | $4.40 | $3.71 | $13.74 |
| % of 52W HighCurrent price vs 52-week peak | +96.6% | +71.2% | +84.7% | +36.4% |
| RSI (14)Momentum oscillator 0–100 | 82.2 | 74.1 | 67.1 | 54.5 |
| Avg Volume (50D)Average daily shares traded | 299K | 5.5M | 59K | 34.9M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: TBRG as "Hold", TDOC as "Hold", HIMS as "Hold". Consensus price targets imply 15.6% upside for HIMS (target: $30) vs -1.3% for TBRG (target: $25).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | — | Hold |
| Price TargetConsensus 12-month target | $25.44 | $7.58 | — | $29.67 |
| # AnalystsCovering analysts | 22 | 42 | — | 19 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | — | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.5% | 0.0% | +0.0% | +1.4% |
HIMS leads in 2 of 6 categories (Income & Cash Flow, Total Returns). TDOC leads in 1 (Valuation Metrics). 1 tied.
TBRG vs TDOC vs AMWL vs HIMS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is TBRG or TDOC or AMWL or HIMS a better buy right now?
For growth investors, Hims & Hers Health, Inc.
(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus -2. 0% for American Well Corporation (AMWL). Hims & Hers Health, Inc. (HIMS) offers the better valuation at 50. 3x trailing P/E (51. 5x forward), making it the more compelling value choice. Analysts rate TruBridge, Inc. (TBRG) a "Hold" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TBRG or TDOC or AMWL or HIMS?
On trailing P/E, Hims & Hers Health, Inc.
(HIMS) is the cheapest at 50. 3x versus TruBridge, Inc. at 88. 9x. On forward P/E, TruBridge, Inc. is actually cheaper at 10. 1x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — TBRG or TDOC or AMWL or HIMS?
Over the past 5 years, Hims & Hers Health, Inc.
(HIMS) delivered a total return of +137. 6%, compared to -97. 2% for American Well Corporation (AMWL). Over 10 years, the gap is even starker: HIMS returned +161. 9% versus AMWL's -98. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TBRG or TDOC or AMWL or HIMS?
By beta (market sensitivity over 5 years), TruBridge, Inc.
(TBRG) is the lower-risk stock at 0. 94β versus Hims & Hers Health, Inc. 's 2. 40β — meaning HIMS is approximately 154% more volatile than TBRG relative to the S&P 500. On balance sheet safety, American Well Corporation (AMWL) carries a lower debt/equity ratio of 2% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — TBRG or TDOC or AMWL or HIMS?
By revenue growth (latest reported year), Hims & Hers Health, Inc.
(HIMS) is pulling ahead at 59. 0% versus -2. 0% for American Well Corporation (AMWL). On earnings-per-share growth, the picture is similar: TruBridge, Inc. grew EPS 121. 0% year-over-year, compared to -3. 8% for Hims & Hers Health, Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TBRG or TDOC or AMWL or HIMS?
Hims & Hers Health, Inc.
(HIMS) is the more profitable company, earning 5. 5% net margin versus -38. 4% for American Well Corporation — meaning it keeps 5. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TBRG leads at 9. 7% versus -42. 2% for AMWL. At the gross margin level — before operating expenses — TDOC leads at 69. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TBRG or TDOC or AMWL or HIMS more undervalued right now?
On forward earnings alone, TruBridge, Inc.
(TBRG) trades at 10. 1x forward P/E versus 51. 5x for Hims & Hers Health, Inc. — 41. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HIMS: 15. 6% to $29. 67.
08Which pays a better dividend — TBRG or TDOC or AMWL or HIMS?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is TBRG or TDOC or AMWL or HIMS better for a retirement portfolio?
For long-horizon retirement investors, TruBridge, Inc.
(TBRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94)). Teladoc Health, Inc. (TDOC) carries a higher beta of 1. 91 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (TBRG: -36. 0%, TDOC: -41. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TBRG and TDOC and AMWL and HIMS?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: TBRG is a small-cap quality compounder stock; TDOC is a small-cap quality compounder stock; AMWL is a small-cap quality compounder stock; HIMS is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.